The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality ...

Millions of South Africa are suffering with symptoms generally known as Long Covid. This growing crisis is shattering lives, ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

While many people recover from Covid at home, some require additional medical intervention. Here are the red flag symptoms you should look out for ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...

A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...

People with immune system health problems continue to take precautions against COVID-19 five years into the pandemic.

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

When you have Covid, there’s a phase when the virus is quickly replicating, followed by an inflammatory response phase when your body fights off the virus, explained Dr. Mahdee Sobhanie ...